Monthly Archives: December 2015

E

The Pope has inaugurated a new holy year of mercy by opening the splendid doors of a Vatican chapel. He intoned (but not in Hebrew) the words of Psalm 118: Open for me the Gates of Righteousness. In Hebrew the same text is part of the Yom Kippur liturgy. Because of the way the Hebrew…

The Lesson Of Economic Crises History: Be Prepared

We tend to think of economic crises as relatively rare, isolated events like the Great Depression or the 2008 meltdown. But in truth, they are pretty common. They’ve been happening for thousands of years, and few generations escape them. This fascinating video by HowMuch graphically illustrates the history of economic crises. Video Length: 00:06:24 The…

Market Talk – December 11th, 2015

Asia managed a mixed session torn between the falling oil price and the Dow’s rally. Europe was very sure what should happen when oil was hit again this morning. When WTI and Brent fell another 1.5% on the back of an earlier report from the IEA (International Energy Agency) that they are forecasting  a slack in…

Hanging On

Over the past week, my market health indicators mostly fell, but none of them fell enough to change any portfolio allocations. The market trend category is the closest to going negative, but still hanging on. One thing of note this week is that fear is starting to enter the market. Two of the four components…

Hanging On

Over the past week, my market health indicators mostly fell, but none of them fell enough to change any portfolio allocations. The market trend category is the closest to going negative, but still hanging on. One thing of note this week is that fear is starting to enter the market. Two of the four components…

The Good News Is, Walmart Stock Is Now Available At A Walmart Pri

You can now get Walmart (NYSE:WMT) at a Walmart price, and its a bargain, like I’ve said before. Consider this. The market cap of $191 billion is less than 40% of the current year’s estimated sales of $500 billion. Compare the current Price/Earnings multiple, at 12.7, with nearly 17 at its main competitor, Target (NYSE:TGT) or 20 at another primary…

E

The Wyden-Grassley report has ruffled some feathers in the pharmaceutical industry. The 18 month investigation determined that Gilead GILD priced Sovaldi ($1,000 pill per day) to maximize revenue; R&D costs or the multi-billion acquisition of Pharmasset may not have factored into the price. The takeaway from the report is clear — there could be justification…